Detalles de la búsqueda
1.
Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands.
Ann Surg Oncol
; 29(8): 4833-4843, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552938
2.
Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands.
BMC Cancer
; 19(1): 58, 2019 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642296
3.
ASO Author Reflections: The PlasmaJet® Device Contributes to an Increase in the Number of Complete Cytoreductive Surgeries for Ovarian Cancer Patients.
Ann Surg Oncol
; 29(8): 4844-4845, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482266
4.
Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.
Eur J Gynaecol Oncol
; 37(1): 63-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27048112
5.
Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.
Eur J Cancer
; 46(1): 102-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19900801
Resultados
1 -
5
de 5
1
Próxima >
>>